Literature DB >> 17978309

Risk of kidney injury following oral phosphosoda bowel preparations.

Steven M Brunelli1, James D Lewis, Meera Gupta, Sherif M Latif, Mark G Weiner, Harold I Feldman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17978309     DOI： 10.1681/ASN.2007040440

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  17 in total

1.  A murine model of phosphate nephropathy.

Authors:  Philipp Eller; Kathrin Eller; Alexander H Kirsch; Josef J Patsch; Anna M Wolf; Andrea Tagwerker; Ursula Stanzl; Reinhard Kaindl; Volker Kahlenberg; Gert Mayer; Josef R Patsch; Alexander R Rosenkranz
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

Review 2.  Colon cleansing before colonoscopy: does oral sodium phosphate solution still make sense?

Authors:  D K Rex; S J Vanner
Journal:  Can J Gastroenterol       Date:  2009-03       Impact factor: 3.522

Review 3.  The safety of osmotically acting cathartics in colonic cleansing.

Authors:  Caroline Nyberg; Jakob Hendel; Ole H Nielsen
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-08-24       Impact factor: 46.802

4.  Acute kidney injury following implementation of an enhanced recovery after surgery (ERAS) protocol in colorectal surgery.

Authors:  Joseph H Marcotte; Kinjal Patel; Ronak Desai; John P Gaughan; Deviney Rattigan; Kevin W Cahill; Robin F Irons; Justin Dy; Monika Dobrowolski; Helena McElhenney; Michael Kwiatt; Steven McClane
Journal:  Int J Colorectal Dis       Date:  2018-05-28       Impact factor: 2.571

5.  Sodium phosphate does not increase risk for acute kidney injury after routine colonoscopy, compared with polyethylene glycol.

Authors:  J Bradley Layton; Philip J Klemmer; Christian F Christiansen; Andrew S Bomback; John A Baron; Robert S Sandler; Abhijit V Kshirsagar
Journal:  Clin Gastroenterol Hepatol       Date:  2014-01-29       Impact factor: 11.382

6.  Design and analysis of multiple events case-control studies.

Authors:  Wenguang Sun; Marshall M Joffe; Jinbo Chen; Steven M Brunelli
Journal:  Biometrics       Date:  2010-12       Impact factor: 2.571

7.  A prospective assessment of renal impairment after preparation for colonoscopy: oral sodium phosphate appears to be safe in well-hydrated subjects with normal renal status.

Authors:  M A Korsten; A M Spungen; A R Rosman; H R Ancha; J B Post; S Shaw; K K Hunt; R Williams; W A Bauman
Journal:  Dig Dis Sci       Date:  2009-10-16       Impact factor: 3.199

8.  Incidence and outcome of acute phosphate nephropathy in Iceland.

Authors:  Vala Kolbrún Pálmadóttir; Hjalti Gudmundsson; Sverrir Hardarson; Margrét Arnadóttir; Thorvaldur Magnússon; Margrét B Andrésdóttir
Journal:  PLoS One       Date:  2010-10-19       Impact factor: 3.240

Review 9.  Adverse renal and metabolic effects associated with oral sodium phosphate bowel preparation.

Authors:  Eliot C Heher; Samuel O Thier; Helmut Rennke; Benjamin D Humphreys
Journal:  Clin J Am Soc Nephrol       Date:  2008-07-02       Impact factor: 8.237

10.  A comparison of sodium phosphosoda purgative to polyethylene glycol bowel preparations prior to colonoscopy.

Authors:  Steven M Brunelli; Harold I Feldman; Sherif M Latif; Meera Gupta; Mark G Weiner; James D Lewis
Journal:  Fam Med       Date:  2009-01       Impact factor: 1.756
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.